| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Deacetylases | 12 | 2021 | 364 | 3.320 |
Why?
|
| NF-E2-Related Factor 2 | 16 | 2013 | 250 | 2.000 |
Why?
|
| Circadian Rhythm | 8 | 2022 | 331 | 1.930 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 5 | 2019 | 69 | 1.840 |
Why?
|
| Insulin Resistance | 7 | 2021 | 730 | 1.710 |
Why?
|
| Fatty Liver | 8 | 2021 | 234 | 1.610 |
Why?
|
| Liver | 11 | 2021 | 2904 | 1.590 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 4 | 2019 | 45 | 1.570 |
Why?
|
| Muscle, Skeletal | 6 | 2019 | 1276 | 1.530 |
Why?
|
| Arsenic | 3 | 2021 | 48 | 1.430 |
Why?
|
| Co-Repressor Proteins | 2 | 2020 | 121 | 1.410 |
Why?
|
| GABAergic Neurons | 2 | 2021 | 47 | 1.410 |
Why?
|
| Circadian Clocks | 7 | 2022 | 66 | 1.360 |
Why?
|
| Lipid Metabolism | 8 | 2017 | 481 | 1.220 |
Why?
|
| Antioxidants | 8 | 2013 | 514 | 1.030 |
Why?
|
| Gene Expression Regulation | 16 | 2021 | 4026 | 0.970 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 4 | 2021 | 21 | 0.970 |
Why?
|
| Glucose | 6 | 2021 | 1246 | 0.900 |
Why?
|
| Glucose Intolerance | 2 | 2021 | 82 | 0.890 |
Why?
|
| Diet, High-Fat | 3 | 2021 | 241 | 0.870 |
Why?
|
| Suprachiasmatic Nucleus | 2 | 2021 | 24 | 0.830 |
Why?
|
| Energy Metabolism | 6 | 2021 | 994 | 0.800 |
Why?
|
| Paternal Exposure | 1 | 2021 | 9 | 0.790 |
Why?
|
| Myocardium | 2 | 2022 | 1294 | 0.770 |
Why?
|
| Hypothalamus | 2 | 2021 | 255 | 0.750 |
Why?
|
| Animals | 49 | 2022 | 59506 | 0.730 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 10 | 0.730 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2020 | 76 | 0.710 |
Why?
|
| Poisons | 1 | 2019 | 9 | 0.700 |
Why?
|
| Mice | 38 | 2022 | 34407 | 0.680 |
Why?
|
| Growth Disorders | 1 | 2021 | 218 | 0.680 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 14 | 0.680 |
Why?
|
| Hypoglycemia | 1 | 2020 | 212 | 0.640 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 231 | 0.620 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2019 | 612 | 0.590 |
Why?
|
| Adenosine | 1 | 2019 | 291 | 0.590 |
Why?
|
| Muscle Fatigue | 1 | 2016 | 13 | 0.590 |
Why?
|
| Pro-Opiomelanocortin | 4 | 2021 | 113 | 0.580 |
Why?
|
| Physical Endurance | 1 | 2016 | 58 | 0.570 |
Why?
|
| Mice, Knockout | 14 | 2022 | 5672 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 15 | 2021 | 6912 | 0.570 |
Why?
|
| Muscle Strength | 1 | 2016 | 106 | 0.550 |
Why?
|
| Body Weight | 1 | 2021 | 1292 | 0.550 |
Why?
|
| Memory Disorders | 1 | 2019 | 295 | 0.550 |
Why?
|
| Physical Conditioning, Animal | 1 | 2016 | 112 | 0.530 |
Why?
|
| Memory | 1 | 2019 | 429 | 0.520 |
Why?
|
| Intellectual Disability | 2 | 2020 | 1029 | 0.520 |
Why?
|
| Proteome | 1 | 2019 | 562 | 0.510 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 371 | 0.490 |
Why?
|
| Obesity | 3 | 2022 | 2893 | 0.490 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 9 | 2013 | 1267 | 0.490 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 987 | 0.490 |
Why?
|
| RNA | 1 | 2019 | 1011 | 0.480 |
Why?
|
| Meiosis | 3 | 2021 | 166 | 0.480 |
Why?
|
| Chronic Disease | 1 | 2019 | 1836 | 0.470 |
Why?
|
| Seizures | 1 | 2020 | 988 | 0.470 |
Why?
|
| Transcriptome | 2 | 2019 | 1859 | 0.450 |
Why?
|
| Transcription, Genetic | 4 | 2019 | 3127 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2021 | 1360 | 0.440 |
Why?
|
| Lipids | 2 | 2016 | 644 | 0.430 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 905 | 0.420 |
Why?
|
| Gene Deletion | 2 | 2021 | 1440 | 0.410 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 120 | 0.400 |
Why?
|
| Hepatocytes | 1 | 2013 | 347 | 0.400 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 10 | 2013 | 104 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 1435 | 0.390 |
Why?
|
| Cell Nucleolus | 1 | 2011 | 89 | 0.380 |
Why?
|
| Phenotype | 2 | 2020 | 6265 | 0.370 |
Why?
|
| Lipogenesis | 4 | 2019 | 77 | 0.370 |
Why?
|
| Cytoskeletal Proteins | 2 | 2011 | 493 | 0.340 |
Why?
|
| DNA Methylation | 1 | 2019 | 2671 | 0.340 |
Why?
|
| Spermatogenesis | 3 | 2021 | 308 | 0.340 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2009 | 109 | 0.320 |
Why?
|
| Histones | 3 | 2021 | 1467 | 0.320 |
Why?
|
| Glucose Clamp Technique | 2 | 2019 | 89 | 0.320 |
Why?
|
| Sex Chromosomes | 2 | 2019 | 42 | 0.320 |
Why?
|
| Neurons | 5 | 2021 | 2289 | 0.320 |
Why?
|
| Transcriptional Activation | 3 | 2021 | 1067 | 0.310 |
Why?
|
| Neural Pathways | 2 | 2019 | 297 | 0.300 |
Why?
|
| Epigenesis, Genetic | 4 | 2019 | 1396 | 0.290 |
Why?
|
| Brain | 1 | 2020 | 4111 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2009 | 640 | 0.280 |
Why?
|
| Response Elements | 3 | 2018 | 194 | 0.280 |
Why?
|
| Genomics | 1 | 2017 | 2745 | 0.270 |
Why?
|
| Proteomics | 3 | 2018 | 1382 | 0.270 |
Why?
|
| Acetylation | 4 | 2021 | 511 | 0.250 |
Why?
|
| Cell Line | 9 | 2021 | 5083 | 0.250 |
Why?
|
| Diet | 1 | 2011 | 1451 | 0.230 |
Why?
|
| Male | 23 | 2021 | 123269 | 0.220 |
Why?
|
| SOX Transcription Factors | 2 | 2021 | 2 | 0.220 |
Why?
|
| Spermatids | 2 | 2021 | 42 | 0.210 |
Why?
|
| Overnutrition | 1 | 2021 | 15 | 0.210 |
Why?
|
| Cell Nucleus | 1 | 2007 | 1616 | 0.200 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2021 | 421 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 3081 | 0.200 |
Why?
|
| Humans | 33 | 2022 | 262184 | 0.200 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2021 | 35 | 0.200 |
Why?
|
| Osteocalcin | 1 | 2021 | 84 | 0.200 |
Why?
|
| Oxidative Stress | 7 | 2018 | 1131 | 0.200 |
Why?
|
| Hunger | 1 | 2021 | 47 | 0.200 |
Why?
|
| Photoperiod | 1 | 2021 | 31 | 0.200 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 32 | 0.190 |
Why?
|
| Ubiquitin | 3 | 2009 | 344 | 0.190 |
Why?
|
| Adipocytes, White | 1 | 2021 | 34 | 0.190 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2021 | 36 | 0.190 |
Why?
|
| Lipodystrophy | 1 | 2021 | 44 | 0.190 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 84 | 0.190 |
Why?
|
| Lipolysis | 1 | 2021 | 109 | 0.190 |
Why?
|
| Benzazepines | 1 | 2021 | 109 | 0.190 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2021 | 93 | 0.190 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 2 | 2017 | 29 | 0.180 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2021 | 208 | 0.180 |
Why?
|
| Neurosecretory Systems | 1 | 2020 | 66 | 0.180 |
Why?
|
| HEK293 Cells | 4 | 2021 | 1502 | 0.180 |
Why?
|
| Serotonin | 1 | 2021 | 262 | 0.180 |
Why?
|
| Behavior | 1 | 2020 | 102 | 0.180 |
Why?
|
| Genes, X-Linked | 1 | 2020 | 66 | 0.180 |
Why?
|
| Fasting | 1 | 2021 | 350 | 0.180 |
Why?
|
| Genes, Reporter | 3 | 2021 | 798 | 0.180 |
Why?
|
| Weight Loss | 2 | 2021 | 629 | 0.180 |
Why?
|
| Anhedonia | 1 | 2019 | 39 | 0.170 |
Why?
|
| Ubiquitination | 6 | 2013 | 578 | 0.170 |
Why?
|
| Glycerolphosphate Dehydrogenase | 1 | 2019 | 4 | 0.170 |
Why?
|
| Pachytene Stage | 1 | 2019 | 2 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 132 | 0.170 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 176 | 0.170 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 49 | 0.170 |
Why?
|
| Resistance Training | 1 | 2019 | 42 | 0.170 |
Why?
|
| Fatty Acids | 2 | 2019 | 449 | 0.170 |
Why?
|
| Cullin Proteins | 3 | 2010 | 41 | 0.170 |
Why?
|
| NIH 3T3 Cells | 2 | 2011 | 262 | 0.170 |
Why?
|
| Feeding and Eating Disorders | 1 | 2019 | 97 | 0.170 |
Why?
|
| Receptors, GABA-A | 1 | 2019 | 79 | 0.160 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hyperglycemia | 1 | 2021 | 333 | 0.160 |
Why?
|
| Atrial Remodeling | 1 | 2018 | 12 | 0.160 |
Why?
|
| Fertility | 1 | 2021 | 335 | 0.160 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2011 | 323 | 0.160 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 39 | 0.160 |
Why?
|
| Transfection | 4 | 2013 | 2934 | 0.160 |
Why?
|
| Arsenites | 2 | 2008 | 17 | 0.160 |
Why?
|
| Feeding Behavior | 2 | 2021 | 810 | 0.160 |
Why?
|
| Endocrine System | 1 | 2018 | 36 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2009 | 521 | 0.160 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 443 | 0.160 |
Why?
|
| Testis | 2 | 2021 | 717 | 0.160 |
Why?
|
| Pyruvic Acid | 1 | 2019 | 132 | 0.150 |
Why?
|
| Body Composition | 2 | 2021 | 596 | 0.150 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2019 | 245 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 360 | 0.150 |
Why?
|
| Metabolic Flux Analysis | 1 | 2017 | 27 | 0.150 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2017 | 37 | 0.150 |
Why?
|
| Autonomic Nervous System | 1 | 2018 | 72 | 0.150 |
Why?
|
| AMP Deaminase | 1 | 2016 | 5 | 0.150 |
Why?
|
| Endoribonucleases | 1 | 2018 | 107 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 32 | 0.150 |
Why?
|
| Endothelium, Vascular | 1 | 2021 | 875 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 1222 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2020 | 323 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2021 | 563 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 131 | 0.140 |
Why?
|
| Signal Transduction | 6 | 2021 | 11970 | 0.140 |
Why?
|
| Syndrome | 1 | 2020 | 1352 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 305 | 0.140 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2016 | 95 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2021 | 1242 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 4130 | 0.140 |
Why?
|
| Histone Code | 1 | 2016 | 80 | 0.140 |
Why?
|
| Amino Acids | 1 | 2019 | 727 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2019 | 496 | 0.140 |
Why?
|
| Pedigree | 1 | 2020 | 1889 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 2214 | 0.130 |
Why?
|
| Heart Atria | 1 | 2018 | 352 | 0.130 |
Why?
|
| Fibronectins | 1 | 2016 | 191 | 0.130 |
Why?
|
| Pancreas | 1 | 2019 | 716 | 0.130 |
Why?
|
| Sex Factors | 1 | 2021 | 2156 | 0.130 |
Why?
|
| CLOCK Proteins | 1 | 2015 | 35 | 0.130 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 701 | 0.130 |
Why?
|
| Heart Diseases | 1 | 2022 | 737 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2019 | 551 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2021 | 1046 | 0.130 |
Why?
|
| Metabolism | 1 | 2015 | 55 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2019 | 1545 | 0.130 |
Why?
|
| Calcium | 1 | 2021 | 1548 | 0.120 |
Why?
|
| Sirolimus | 1 | 2019 | 816 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 935 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2016 | 253 | 0.120 |
Why?
|
| Kinetics | 1 | 2017 | 2040 | 0.120 |
Why?
|
| Infertility, Male | 1 | 2017 | 296 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 6064 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 1079 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2013 | 513 | 0.120 |
Why?
|
| Metabolomics | 1 | 2017 | 479 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 677 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 811 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2016 | 3537 | 0.110 |
Why?
|
| Diabetic Retinopathy | 1 | 2016 | 178 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2014 | 159 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 5154 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4234 | 0.110 |
Why?
|
| Protein Binding | 4 | 2016 | 3442 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2019 | 996 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 463 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 601 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2013 | 220 | 0.100 |
Why?
|
| Insulin | 2 | 2021 | 1447 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2019 | 2234 | 0.100 |
Why?
|
| Genes, Mitochondrial | 1 | 2011 | 24 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 1186 | 0.100 |
Why?
|
| alpha Karyopherins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2011 | 18 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 7217 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 719 | 0.100 |
Why?
|
| Estrogens | 1 | 2015 | 748 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 4944 | 0.100 |
Why?
|
| Ventral Tegmental Area | 2 | 2021 | 49 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2013 | 1258 | 0.090 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 2 | 2021 | 50 | 0.090 |
Why?
|
| Female | 12 | 2021 | 142232 | 0.090 |
Why?
|
| Integrases | 1 | 2011 | 262 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 2015 | 766 | 0.090 |
Why?
|
| COS Cells | 2 | 2007 | 377 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 1488 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2011 | 342 | 0.090 |
Why?
|
| Depression | 1 | 2019 | 1715 | 0.090 |
Why?
|
| Quinolones | 1 | 2010 | 159 | 0.080 |
Why?
|
| Diterpenes, Kaurane | 1 | 2008 | 3 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2013 | 1741 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2021 | 3536 | 0.080 |
Why?
|
| Acrolein | 1 | 2008 | 11 | 0.080 |
Why?
|
| Adipose Tissue, White | 2 | 2021 | 100 | 0.080 |
Why?
|
| Sodium Compounds | 1 | 2007 | 6 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2007 | 19 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 5052 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 2504 | 0.070 |
Why?
|
| Light | 1 | 2008 | 247 | 0.070 |
Why?
|
| Heart | 1 | 2014 | 1225 | 0.070 |
Why?
|
| Genome | 1 | 2011 | 673 | 0.070 |
Why?
|
| Animals, Newborn | 1 | 2011 | 1328 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2008 | 193 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 702 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2007 | 86 | 0.070 |
Why?
|
| Arsenicals | 1 | 2007 | 201 | 0.070 |
Why?
|
| Cell Line, Tumor | 6 | 2018 | 14588 | 0.070 |
Why?
|
| Luciferases | 1 | 2007 | 445 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 3636 | 0.070 |
Why?
|
| Echocardiography | 1 | 2011 | 1177 | 0.070 |
Why?
|
| Genotype | 1 | 2013 | 4108 | 0.070 |
Why?
|
| Triglycerides | 2 | 2019 | 604 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 990 | 0.060 |
Why?
|
| Autophagy | 1 | 2010 | 929 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2020 | 16249 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2019 | 2448 | 0.060 |
Why?
|
| Skin | 1 | 2008 | 1259 | 0.050 |
Why?
|
| Satiety Response | 1 | 2021 | 33 | 0.050 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2021 | 10 | 0.050 |
Why?
|
| Ruthenium Compounds | 1 | 2021 | 3 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 130 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2009 | 4813 | 0.050 |
Why?
|
| Appetite | 1 | 2021 | 73 | 0.050 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 165 | 0.050 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 211 | 0.050 |
Why?
|
| Mitoxantrone | 1 | 2021 | 216 | 0.050 |
Why?
|
| Agouti-Related Protein | 1 | 2021 | 51 | 0.050 |
Why?
|
| Time | 1 | 2021 | 179 | 0.050 |
Why?
|
| Mutation | 2 | 2013 | 15185 | 0.050 |
Why?
|
| Adipokines | 1 | 2021 | 96 | 0.050 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 109 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 154 | 0.040 |
Why?
|
| Cell Survival | 2 | 2021 | 3047 | 0.040 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2021 | 125 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 347 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2020 | 333 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2007 | 1661 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 696 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 364 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 15706 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2021 | 194 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5187 | 0.040 |
Why?
|
| Weight Gain | 1 | 2021 | 464 | 0.040 |
Why?
|
| Models, Biological | 1 | 2007 | 3249 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 591 | 0.040 |
Why?
|
| Endocrinology | 1 | 2020 | 139 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 485 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2017 | 15 | 0.040 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2017 | 15 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 115 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2019 | 204 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 775 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 1954 | 0.040 |
Why?
|
| Middle Aged | 2 | 2021 | 86445 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 278 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 2054 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 264 | 0.030 |
Why?
|
| Binding Sites | 2 | 2011 | 2171 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2019 | 836 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2015 | 6 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2008 | 884 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 57 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 767 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 393 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 1189 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 621 | 0.030 |
Why?
|
| Mitochondria | 1 | 2021 | 1284 | 0.030 |
Why?
|
| Neoplasms | 3 | 2010 | 15201 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 2062 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2014 | 118 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 695 | 0.030 |
Why?
|
| Interleukins | 1 | 2016 | 326 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2015 | 878 | 0.030 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2013 | 72 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2013 | 239 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 622 | 0.020 |
Why?
|
| Chronobiology Disorders | 1 | 2011 | 10 | 0.020 |
Why?
|
| Sequestosome-1 Protein | 1 | 2010 | 39 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2011 | 182 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 499 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 4890 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 769 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3830 | 0.020 |
Why?
|
| Genes, Switch | 1 | 2008 | 15 | 0.020 |
Why?
|
| Carcinogens | 1 | 2010 | 383 | 0.020 |
Why?
|
| Biotransformation | 1 | 2008 | 94 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 394 | 0.020 |
Why?
|
| Thiocyanates | 1 | 2007 | 17 | 0.020 |
Why?
|
| Sulfoxides | 1 | 2007 | 22 | 0.020 |
Why?
|
| Hydroquinones | 1 | 2007 | 28 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 1487 | 0.020 |
Why?
|
| Isothiocyanates | 1 | 2007 | 44 | 0.020 |
Why?
|
| Cysteine | 1 | 2008 | 214 | 0.020 |
Why?
|
| Inflammation | 1 | 2016 | 2515 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2017 | 2815 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2013 | 1998 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 4330 | 0.020 |
Why?
|
| Chitin | 1 | 2005 | 5 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 945 | 0.020 |
Why?
|
| Urothelium | 1 | 2007 | 254 | 0.020 |
Why?
|
| Quinones | 1 | 2005 | 21 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 14300 | 0.020 |
Why?
|
| Anticarcinogenic Agents | 1 | 2007 | 362 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 1556 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 2007 | 576 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2007 | 739 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2009 | 2086 | 0.010 |
Why?
|
| Glutathione | 1 | 2005 | 366 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2014 | 4046 | 0.010 |
Why?
|
| DNA | 1 | 2011 | 2680 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2008 | 853 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2005 | 590 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 70323 | 0.010 |
Why?
|
| DNA Repair | 1 | 2009 | 1871 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2007 | 1651 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2005 | 1688 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 1878 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 3563 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 2915 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 5603 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 1554 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 6132 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 7608 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 4794 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 78082 | 0.010 |
Why?
|